Skip to main content
Top
Published in: Addiction Science & Clinical Practice 1/2017

Open Access 01-12-2017 | Research

Integrated HIV care is associated with improved engagement in treatment in an urban methadone clinic

Authors: Claire Simeone, Brad Shapiro, Paula J. Lum

Published in: Addiction Science & Clinical Practice | Issue 1/2017

Login to get access

Abstract

Background

Persons living with HIV and unhealthy substance use are often less engaged in HIV care, have higher morbidity and mortality and are at increased risk of transmitting HIV to uninfected partners. We developed a quality-improvement tracking system at an urban methadone clinic to monitor patients along the HIV care continuum and identify patients needing intervention.

Objective

To evaluate patient outcomes along the HIV Care Continuum at an urban methadone clinic and explore the relationship of HIV primary care site and patient demographic characteristics with retention in HIV treatment and viral suppression.

Methods

We reviewed electronic medical record data from 2015 for all methadone clinic patients with known HIV disease, including age, gender, race, HIV care sites, HIV care visit dates and HIV viral load. Patients received either HIV primary care at the methadone clinic, an HIV specialty clinic located in the adjacent building, or a community clinic. Retention was defined as an HIV primary care visit in both halves of the year. Viral suppression was defined as an HIV viral load <40 copies/ml at the last lab draw.

Results

The population (n = 65) was 63% male, 82% age 45 or older and 60% non-Caucasian. Of these 65 patients 77% (n = 50) were retained in care and 80% (n = 52) were virologically suppressed. Viral suppression was significantly higher for women (p = .022) and patients 45 years or older (p = .034). There was a trend towards greater retention in care and viral suppression among patients receiving HIV care at the methadone clinic (93, 93%) compared to the HIV clinic (74, 79%) or community clinics (62, 62%).

Conclusions

Retention in HIV care and viral suppression are high in an urban methadone clinic providing integrated HIV services. This quality improvement analysis supports integrating HIV primary care with methadone treatment services for this at-risk population.
Literature
1.
go back to reference Altice FL, Kamarulzaman A, Soriano VV, Schechter M, Freidland GH. Treatment of medical, psychiatric and substance-use comorbidities in people infected with HIV who use drugs. Lancet. 2010;376(9738):50–79.CrossRef Altice FL, Kamarulzaman A, Soriano VV, Schechter M, Freidland GH. Treatment of medical, psychiatric and substance-use comorbidities in people infected with HIV who use drugs. Lancet. 2010;376(9738):50–79.CrossRef
2.
go back to reference Campbell AC, Tross S, Calysn DA. Substance use disorders and HIV/AIDS prevention and treatment intervention: research and practice considerations. Soc Work Pub Health. 2012;28:333–48.CrossRef Campbell AC, Tross S, Calysn DA. Substance use disorders and HIV/AIDS prevention and treatment intervention: research and practice considerations. Soc Work Pub Health. 2012;28:333–48.CrossRef
4.
go back to reference Spiller MW, Broz D, Wenjert C, Nerlander L, Paz-Bailey G. HIV infection and HIV-associated behaviors among persons who inject drugs- 20 cities, United States, 2012. MMWR. 2015;64(10):270–5.PubMed Spiller MW, Broz D, Wenjert C, Nerlander L, Paz-Bailey G. HIV infection and HIV-associated behaviors among persons who inject drugs- 20 cities, United States, 2012. MMWR. 2015;64(10):270–5.PubMed
5.
go back to reference Gardner EM, McLees MP, Steiner JF, del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for HIV prevention. Clin Infect Dis. 2011;52:793–800.CrossRefPubMedPubMedCentral Gardner EM, McLees MP, Steiner JF, del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for HIV prevention. Clin Infect Dis. 2011;52:793–800.CrossRefPubMedPubMedCentral
7.
go back to reference Bradley H, Hall IH, Wolitski RJ, et al. Vital signs: HIV diagnosis, care and treatment among persons living with HIV-United States, 2011. MMWR. 2014;63(47):1113–7.PubMed Bradley H, Hall IH, Wolitski RJ, et al. Vital signs: HIV diagnosis, care and treatment among persons living with HIV-United States, 2011. MMWR. 2014;63(47):1113–7.PubMed
9.
go back to reference Levi J, Raymond A, Pozniak A, et al. Can the UNAIDS 90-90-90 target be reached? Analysis of national treatment cascades. In: 8th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention (IAS 2015), Vancouver, BC. Presented 20 July 2015. Levi J, Raymond A, Pozniak A, et al. Can the UNAIDS 90-90-90 target be reached? Analysis of national treatment cascades. In: 8th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention (IAS 2015), Vancouver, BC. Presented 20 July 2015.
10.
go back to reference McMahon JH, Elliott JH, Bertagnolio S, et al. Viral suppression after 12 months of antiretroviral therapy in low- and middle-income countries: a systematic review. Bull World Health Org. 2013;91:377–85.CrossRefPubMedPubMedCentral McMahon JH, Elliott JH, Bertagnolio S, et al. Viral suppression after 12 months of antiretroviral therapy in low- and middle-income countries: a systematic review. Bull World Health Org. 2013;91:377–85.CrossRefPubMedPubMedCentral
11.
go back to reference UNAIDS. The gap report. Joint United Nations Programme on HIV/AIDS. 2014. Geneva, Switzerland. UNAIDS. The gap report. Joint United Nations Programme on HIV/AIDS. 2014. Geneva, Switzerland.
12.
go back to reference Samet JH, Freidmann P, Saitz R. Benefits of linking primary medical care and substance abuse services. Arch Int Med. 2001;161:85–91.CrossRef Samet JH, Freidmann P, Saitz R. Benefits of linking primary medical care and substance abuse services. Arch Int Med. 2001;161:85–91.CrossRef
13.
go back to reference Palepu A, Tyndall MW, Joy R, et al. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy. Drug Alc Dep. 2006;84:188–94.CrossRef Palepu A, Tyndall MW, Joy R, et al. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy. Drug Alc Dep. 2006;84:188–94.CrossRef
14.
go back to reference Uhlmann S, Milloy MJ, Kerr T, et al. Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users. Addiction. 2010;105(5):907–13.CrossRefPubMedPubMedCentral Uhlmann S, Milloy MJ, Kerr T, et al. Methadone maintenance therapy promotes initiation of antiretroviral therapy among injection drug users. Addiction. 2010;105(5):907–13.CrossRefPubMedPubMedCentral
15.
go back to reference Roux P, Carrieri MP, Villes V, et al. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study. Addiction. 2008;103:1828–36.CrossRefPubMed Roux P, Carrieri MP, Villes V, et al. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study. Addiction. 2008;103:1828–36.CrossRefPubMed
18.
go back to reference IBM Corp. IBM SPSS Statistics, Version 23.0.0.2. Armonk, NY: IBM Corp; 2015. IBM Corp. IBM SPSS Statistics, Version 23.0.0.2. Armonk, NY: IBM Corp; 2015.
20.
go back to reference Chandler G, Himelhoch S, Moore RD. Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy. Drugs. 2006;66(6):769–89.CrossRef Chandler G, Himelhoch S, Moore RD. Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy. Drugs. 2006;66(6):769–89.CrossRef
21.
go back to reference Rothman J, Rudnick D, Slifer M, Agins B, Heiner K, Birkhead G. Co-located substance use treatment and HIV prevention and primary care services, New York State, 1990-2002: a model for effective service delivery to high risk population. J Urb Health. 2012;84(2):226–42.CrossRef Rothman J, Rudnick D, Slifer M, Agins B, Heiner K, Birkhead G. Co-located substance use treatment and HIV prevention and primary care services, New York State, 1990-2002: a model for effective service delivery to high risk population. J Urb Health. 2012;84(2):226–42.CrossRef
22.
go back to reference U.S. Department of Health and Human Services (HHS), Office of the Surgeon General. Facing addiction in America: The Surgeon General’s Report on Alcohol, Drugs and Health. Washington, DC: HHS, November 2016. U.S. Department of Health and Human Services (HHS), Office of the Surgeon General. Facing addiction in America: The Surgeon General’s Report on Alcohol, Drugs and Health. Washington, DC: HHS, November 2016.
23.
go back to reference Belani H, Chorba T, Fletcher F, et al. Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from the CDC and the U.S. Department of Health and Human Services. MMWR. 2012;61(RR05):1–40. Belani H, Chorba T, Fletcher F, et al. Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and tuberculosis for persons who use drugs illicitly: summary guidance from the CDC and the U.S. Department of Health and Human Services. MMWR. 2012;61(RR05):1–40.
24.
go back to reference Centers for Disease Control and Prevention. Program collaboration and service integration: enhancing the prevention and control of HIV/AIDS, viral hepatitis, sexually transmitted diseases, and tuberculosis in the United States. Atlanta: U.S. Department of Health and Human Services; 2009. Centers for Disease Control and Prevention. Program collaboration and service integration: enhancing the prevention and control of HIV/AIDS, viral hepatitis, sexually transmitted diseases, and tuberculosis in the United States. Atlanta: U.S. Department of Health and Human Services; 2009.
25.
go back to reference Substance Abuse and Mental Health Services Administration. Innovations in addictions treatment: addiction treatment providers working with primary care services. Washington: Center for Integrated Health Solutions; 2013. Substance Abuse and Mental Health Services Administration. Innovations in addictions treatment: addiction treatment providers working with primary care services. Washington: Center for Integrated Health Solutions; 2013.
26.
go back to reference Haynes LF, Kortbe JE, Holmes BE, et al. HIV rapid testing in substance abuse treatment: implementation following a clinical trial. Eval Prog Plan. 2011;34(4):399–406.CrossRef Haynes LF, Kortbe JE, Holmes BE, et al. HIV rapid testing in substance abuse treatment: implementation following a clinical trial. Eval Prog Plan. 2011;34(4):399–406.CrossRef
27.
go back to reference Hood KB, Robertson AA, Baird-Thomas C. Implementing solutions to barriers to on-site HIV testing in substance abuse treatment: a tale of three facilities. Eval Program Plan. 2015;49:1–9.CrossRef Hood KB, Robertson AA, Baird-Thomas C. Implementing solutions to barriers to on-site HIV testing in substance abuse treatment: a tale of three facilities. Eval Program Plan. 2015;49:1–9.CrossRef
28.
go back to reference Metsch LR, Feaster DJ, Gooden L, et al. Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: results of a randomized trial. Am J Pub Health. 2012;102(6):1160–7.CrossRef Metsch LR, Feaster DJ, Gooden L, et al. Implementing rapid HIV testing with or without risk-reduction counseling in drug treatment centers: results of a randomized trial. Am J Pub Health. 2012;102(6):1160–7.CrossRef
29.
go back to reference Altice FL, Springer S, Buitrago M, Hunt DP, Friedland GH. Pilot study to enhance HIV care using needle exchange-based health services for out-of-treatment injecting drug users. J Urban Health. 2003;80(3):416–27.CrossRefPubMedPubMedCentral Altice FL, Springer S, Buitrago M, Hunt DP, Friedland GH. Pilot study to enhance HIV care using needle exchange-based health services for out-of-treatment injecting drug users. J Urban Health. 2003;80(3):416–27.CrossRefPubMedPubMedCentral
30.
go back to reference Sylla L, Bruce RD, Kamarulzaman A, Altice FL. Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services. Int J Drug Policy. 2007;18:306–12.CrossRefPubMedPubMedCentral Sylla L, Bruce RD, Kamarulzaman A, Altice FL. Integration and co-location of HIV/AIDS, tuberculosis and drug treatment services. Int J Drug Policy. 2007;18:306–12.CrossRefPubMedPubMedCentral
31.
go back to reference Smith-Rohrberg D, Mezger J, Walton M, Bruce D, Altice F. Impact of enhanced services on virologic outcomes in a directly administered antiretroviral therapy trail for HIV = infected drug users. J Acquir Immune Defic Syndr. 2006;43(S1):S48–53.CrossRefPubMed Smith-Rohrberg D, Mezger J, Walton M, Bruce D, Altice F. Impact of enhanced services on virologic outcomes in a directly administered antiretroviral therapy trail for HIV = infected drug users. J Acquir Immune Defic Syndr. 2006;43(S1):S48–53.CrossRefPubMed
32.
go back to reference Umbricht-Schneiter A, Ginn DH, Pabst KM, Bigelow GE. Providing medical care to methadone clinic patients: referral vs on-site care. Am J Pub Health. 1994;84(2):207–10.CrossRef Umbricht-Schneiter A, Ginn DH, Pabst KM, Bigelow GE. Providing medical care to methadone clinic patients: referral vs on-site care. Am J Pub Health. 1994;84(2):207–10.CrossRef
33.
go back to reference Aziz M, Smith KY. Challenges and successes in linking HIV-infected women to care in the United States. Clin Inf Dis. 2011;52(Suppl 2):S231–7.CrossRef Aziz M, Smith KY. Challenges and successes in linking HIV-infected women to care in the United States. Clin Inf Dis. 2011;52(Suppl 2):S231–7.CrossRef
35.
go back to reference Kapogiannis BG, Xu J, Mayer KH. The HIV continuum of care for adolescents and young adults (12–24 years) attending 13 urban US centers of the NICHD-ATN-CDC-HRSA SMILE collaborative. In 8th international AIDS society conference on HIV pathogenesis, treatment, and prevention (IAS 2015), Vancouver, BC. Abstract WELBPE16, 2015. http://www.natap.org/2015/IAS/IAS_42.htm. Accessed 10 March 2016. Kapogiannis BG, Xu J, Mayer KH. The HIV continuum of care for adolescents and young adults (12–24 years) attending 13 urban US centers of the NICHD-ATN-CDC-HRSA SMILE collaborative. In 8th international AIDS society conference on HIV pathogenesis, treatment, and prevention (IAS 2015), Vancouver, BC. Abstract WELBPE16, 2015. http://​www.​natap.​org/​2015/​IAS/​IAS_​42.​htm. Accessed 10 March 2016.
38.
go back to reference Ngyuen QC, Miller M. Health San Francisco: a case study of city-level health reform. Boston MA: Community Catalyst; 2008. Ngyuen QC, Miller M. Health San Francisco: a case study of city-level health reform. Boston MA: Community Catalyst; 2008.
Metadata
Title
Integrated HIV care is associated with improved engagement in treatment in an urban methadone clinic
Authors
Claire Simeone
Brad Shapiro
Paula J. Lum
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Addiction Science & Clinical Practice / Issue 1/2017
Electronic ISSN: 1940-0640
DOI
https://doi.org/10.1186/s13722-017-0084-y

Other articles of this Issue 1/2017

Addiction Science & Clinical Practice 1/2017 Go to the issue